patent on semaglutide A Snapshot of the Landscape Massive Rs 50,000 Cr Opportunity

Its role in improving long-term health outcomes makes semaglutide a valuable component of modern therapeutic strategies for managing complex metabolic diseases

Eli Lilly and Novo Nordisk dominate the GLP-1 market, and most payers secure access through competitive rebate contracts, offering discounts of 35%-50%

En esta entrada, exploraremos la fisiologa del GLP-1, el mecanismo de accin de sus agonistas, sus indicaciones clnicas, y las consideraciones prcticas para su uso

Green tea extract liver safety: High-dose green tea extract, as used in some supplements, has been associated with rare but serious liver injury (hepatotoxicity)